The use of aromatase inhibitors for the treatment of endometriosis is thoroughly reviewed in the clinical Endometriosis Guidelines issued by the European Society of Human Reproduction and Embryology (updated in 2022; (Becker et al., 2022). Here, CYP19A1 is linked to endometriosis.